Global organ transplant diagnostics market will reach $6,072.1 million by 2031, growing by 8.8% annually over 2021-2031, driven by the growing number of transplantations & prevalence of chronic diseases, the high demand for molecular diagnostic tests, the availability of technologically advanced devices, and the surging investment and expenditure in healthcare and diagnostics.
Highlighted with 91 tables and 94 figures, this 185-page report “Global Organ Transplant Diagnostics Market 2021-2031 by Offering (Instruments, Test Kits & Consumables, Software & Services), Transplant (Solid Organ, Stem Cell, Soft Tissue), Application (Diagnostics, Translational Research), Technology (Molecular Technologies, Serology, Flow Cytometry, Others), End User (Hospitals and Transplant Centers, Reference Laboratories, Academic and Research Institutions, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global organ transplant diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global organ transplant diagnostics market in every aspect of the classification from perspectives of Offering, Transplant, Application, Technology, End User, and Region.
Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Test Kits & Consumables
o Kits & Assays
o Consumables
• Software & Services
Based on Transplant, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Solid Organ Transplant
o Kidney
o Liver
o Heart
o Lung
o Pancreas
o Kidney-Pancreas
o Other Solid Organ Transplants
• Stem Cell Transplant
• Soft Tissue Transplant
By Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Diagnostics
o Donor Testing
o Recipient Testing
• Translational Research
By Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Molecular Technologies
o PCR
o Sequencing
o Other Molecular Technologies
• Serology
• Flow Cytometry
• Other Technologies
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals and Transplant Centers
• Reference Laboratories
• Academic and Research Institutions
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE，Saudi Arabia， South Africa and Rest of MEA)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of each national market Offering, Transplant and Technology over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories Inc.
ARUP Laboratories
BAG Health Care GmbH
Becton Dickinson and Company
bioMérieux S.A.
Bio-Rad Laboratories, Inc.
CareDx, Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Immucor, Inc.
Laboratory Corporation of America Holdings
Novacyt Group
Omixon Ltd.
OPKO Health
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 34
2.4 Emerging Opportunities and Market Trends 37
2.5 Porter’s Fiver Forces Analysis 41
3 Segmentation of Global Market by Offering 45
3.1 Market Overview by Offering 45
3.2 Instruments 47
3.3 Test Kits & Consumables 49
3.3.1 Kits & Assays 50
3.3.2 Consumables 52
3.4 Software & Services 54
4 Segmentation of Global Market by Transplant 56
4.1 Market Overview by Transplant 56
4.2 Solid Organ Transplant 58
4.2.1 Kidney 60
4.2.2 Liver 61
4.2.3 Heart 62
4.2.4 Lung 63
4.2.5 Pancreas 64
4.2.6 Kidney-Pancreas 65
4.2.7 Other Solid Organ Transplants 66
4.3 Stem Cell Transplant 67
4.4 Soft Tissue Transplant 68
5 Segmentation of Global Market by Application 69
5.1 Market Overview by Application 69
5.2 Diagnostics 71
5.2.1 Donor Testing 72
5.2.2 Recipient Testing 73
5.3 Translational Research 74
6 Segmentation of Global Market by Technology 75
6.1 Market Overview by Technology 75
6.2 Molecular Technologies 77
6.2.1 PCR 79
6.2.2 Sequencing 80
6.2.3 Other Molecular Technologies 81
6.3 Serology 82
6.4 Flow Cytometry 83
6.5 Other Technologies 84
7 Segmentation of Global Market by End User 85
7.1 Market Overview by End User 85
7.2 Hospitals and Transplant Centers 87
7.3 Reference Laboratories 88
7.4 Academic and Research Institutions 89
7.5 Other End Users 90
8 Segmentation of Global Market by Region 91
8.1 Geographic Market Overview 2021-2031 91
8.2 North America Market 2021-2031 by Country 95
8.2.1 Overview of North America Market 95
8.2.2 U.S. 99
8.2.3 Canada 102
8.2.4 Mexico 104
8.3 European Market 2021-2031 by Country 106
8.3.1 Overview of European Market 106
8.3.2 Germany 110
8.3.3 U.K. 112
8.3.4 France 114
8.3.5 Spain 116
8.3.6 Italy 118
8.3.7 Netherlands 120
8.3.8 Rest of European Market 122
8.4 Asia-Pacific Market 2021-2031 by Country 124
8.4.1 Overview of Asia-Pacific Market 124
8.4.2 Japan 128
8.4.3 China 131
8.4.4 Australia 133
8.4.5 India 135
8.4.6 South Korea 137
8.4.7 Rest of APAC Region 139
8.5 South America Market 2021-2031 by Country 141
8.5.1 Argentina 144
8.5.2 Brazil 146
8.5.3 Chile 148
8.5.4 Rest of South America Market 150
8.6 MEA Market 2021-2031 by Country 151
8.6.1 UAE 154
8.6.2 Saudi Arabia 156
8.6.3 South Africa 158
8.6.4 Other National Markets 160
9 Competitive Landscape 161
9.1 Overview of Key Vendors 161
9.2 New Product Launch, Partnership, Investment, and M&A 165
9.3 Company Profiles 166
Abbott Laboratories Inc. 166
ARUP Laboratories 168
BAG Health Care GmbH 169
Becton Dickinson and Company 170
bioMérieux S.A. 171
Bio-Rad Laboratories, Inc. 172
CareDx, Inc. 173
Eurofins Scientific 174
F. Hoffmann-La Roche Ltd. 175
Illumina, Inc. 176
Immucor, Inc. 177
Laboratory Corporation of America Holdings 178
Novacyt Group 179
Omixon Ltd. 180
OPKO Health 181
QIAGEN N.V. 182
Quest Diagnostics Incorporated 183
Thermo Fisher Scientific Inc. 184
RELATED REPORTS 185
List of Tables:
Table 1. Snapshot of Global Organ Transplant Diagnostics Market in Balanced Perspective, 2021-2031 19
Table 2. World Economic Outlook, 2021-2031 23
Table 3. World Economic Outlook, 2021-2023 24
Table 4. World Health Spending by Region, $ bn, 2013-2020 33
Table 5. Main Product Trends and Market Opportunities in Global Organ Transplant Diagnostics Market 37
Table 6. Global Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 45
Table 7. Main Platforms and Key Vendors 48
Table 8. Global Organ Transplant Diagnostics Market: Test Kits & Consumables by Type, 2021-2031, $ mn 49
Table 9. Main Kits & Assays and Key Vendors 51
Table 10. Main Consumables and Key Vendors 53
Table 11. Main Services and Key Vendors 55
Table 12. Global Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 56
Table 13. Global Organ Transplant Diagnostics Market: Solid Organ Transplant by Type, 2021-2031, $ mn 59
Table 14. Global Organ Transplant Diagnostics Market by Application, 2021-2031, $ mn 69
Table 15. Global Organ Transplant Diagnostics Market: Diagnostics by Type, 2021-2031, $ mn 71
Table 16. Global Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 75
Table 17. Global Organ Transplant Diagnostics Market: Molecular Technologies by Type, 2021-2031, $ mn 78
Table 18. Global Organ Transplant Diagnostics Market by End User, 2021-2031, $ mn 85
Table 19. Global Organ Transplant Diagnostics Market by Region, 2021-2031, $ mn 92
Table 20. Leading National Organ Transplant Diagnostics Market, 2021 and 2031, $ mn 94
Table 21. North America Organ Transplant Diagnostics Market by Country, 2021-2031, $ mn 97
Table 22. U.S. Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 101
Table 23. U.S. Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 101
Table 24. U.S. Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 101
Table 25. Canada Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 103
Table 26. Canada Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 103
Table 27. Canada Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 103
Table 28. Mexico Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 105
Table 29. Mexico Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 105
Table 30. Mexico Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 105
Table 31. Europe Organ Transplant Diagnostics Market by Country, 2021-2031, $ mn 109
Table 32. Germany Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 111
Table 33. Germany Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 111
Table 34. Germany Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 111
Table 35. U.K. Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 113
Table 36. U.K. Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 113
Table 37. U.K. Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 113
Table 38. France Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 115
Table 39. France Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 115
Table 40. France Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 115
Table 41. Spain Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 117
Table 42. Spain Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 117
Table 43. Spain Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 117
Table 44. Italy Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 119
Table 45. Italy Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 119
Table 46. Italy Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 119
Table 47. Netherlands Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 121
Table 48. Netherlands Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 121
Table 49. Netherlands Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 121
Table 50. Organ Transplant Diagnostics Market in Rest of Europe by Country, 2021-2031, $ mn 123
Table 51. APAC Organ Transplant Diagnostics Market by Country, 2021-2031, $ mn 126
Table 52. Japan Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 130
Table 53. Japan Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 130
Table 54. Japan Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 130
Table 55. China Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 132
Table 56. China Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 132
Table 57. China Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 132
Table 58. Australia Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 134
Table 59. Australia Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 134
Table 60. Australia Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 134
Table 61. India Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 136
Table 62. India Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 136
Table 63. India Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 136
Table 64. South Korea Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 138
Table 65. South Korea Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 138
Table 66. South Korea Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 138
Table 67. Organ Transplant Diagnostics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 140
Table 68. South America Organ Transplant Diagnostics Market by Country, 2021-2031, $ mn 143
Table 69. Argentina Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 145
Table 70. Argentina Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 145
Table 71. Argentina Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 145
Table 72. Brazil Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 147
Table 73. Brazil Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 147
Table 74. Brazil Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 147
Table 75. Chile Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 149
Table 76. Chile Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 149
Table 77. Chile Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 149
Table 78. MEA Organ Transplant Diagnostics Market by Country, 2021-2031, $ mn 153
Table 79. UAE Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 155
Table 80. UAE Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 155
Table 81. UAE Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 155
Table 82. Saudi Arabia Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 157
Table 83. Saudi Arabia Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 157
Table 84. Saudi Arabia Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 157
Table 85. South Africa Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn 159
Table 86. South Africa Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn 159
Table 87. South Africa Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn 159
Table 88. Breakdown of World Market by Key Vendor, 2021, % 163
Table 89. Abbott Laboratories Inc.: Company Snapshot 166
Table 90. Abbott Laboratories Inc.: Business Segmentation 167
Table 91. Abbott Laboratories Inc.: Product Portfolio 167
